PTEN mutation primarily affects the PTEN phosphatase domain and leads to several diseases including Cowden's and the Bannayan-Riley-Ruvalcaba syndrome, the Lhermitte-Duclos disease, as well as an increased risk of breast, thyroid, and endometrial cancers (Table 1). This evidence concerns the gene PTEN and endometrial cancer.